K4i / 17B01: Compare and contrast the pharmacology of ibuprofen and paracetamol
17B01: Exam Report
Compare and contrast the pharmacology of ibuprofen and paracetamol.
65% of candidates passed this question.
This was a standard compare and contrast question of common analgesic pharmacology and it was generally well answered. The use of a table ensured all areas were covered including class, indications, pharmaceutics, mode of action, pharmacodynamics, pharmacokinetics and adverse effects. The uncertain nature (and possibilities) of the mechanism of action of paracetamol was alluded to in better responses.
Details of the comparative pharmacokinetics were often lacking. Answers should have included a comment on first-pass effect, the significance of the difference in protein binding and the details of metabolism, particularly paracetamol. Metabolism limited to “hepatic metabolism and renal excretion” gained no marks as better responses were more detailed and clearer about the differences between the two drugs. Knowledge of metabolism at therapeutic doses and the effect of overdose were expected. Better answers included potential interactions with other drugs (e.g. warfarin) and contraindications to the use of these drugs.
K4i / 17B01: Compare and contrast the pharmacology of ibuprofen and paracetamol
Chemical
Ibuprofen
Proprionic acid derivative
Paracetamol
An acetanilide derivative
Comments
An acetanilide derivative
Use
Ibuprofen
- Inflammatory MSK disorders
- Post op pain
Paracetamol
- Analgesia
- Antipyretic
Comments
Can be used synergistically for analgesia
Both are common in the post operative setting
Presentatation
Ibuprofen
Tablets 200 – 600mg
Racemic mixture
R-enantiomer → converted to S-enantiomer → S is the pharmacologically active drug
Paracetamol
- Tablets
- Syrup
- Rectal suppositories
IV → glass vial & argon, drug is unstable in O2 rich environment
Comments
Paracetamol has a more favourable administration profile
Dose
Ibuprofen
20mg/kg/day divided doses
Paracetamol
1g QID
Comments
Both easily dosed
Route
Ibuprofen
PO
Paracetamol
PO/PR/IV
Commets
Onset
Ibuprofen
30 mins
Paracetamol
- Peak [ ] 1hr 30mcg/mL
- Therapeutic range 10 – 20mcg/mL
In 4hrs [ ] <10mcg/mL
Comments
Similar onset & offset
DoA
Ibuprofen
2 – 4 hrs
Paracetamol
2 – 4 hrs
Commets
MoA
Ibuprofen
= antiplatelet, analgesia, antipyretic
- Non-selective COX enzyme inhibition
- ↓ synthesis of PGs, prostacyclin & thromboxane
Paracetamol
Antipyretic
- Inhibits central PG synthesis
- Especially PGE in anterior hypothalamus
Analgesia
- Inhibits peripheral Subs P actions
- Potent central PG synthesis
- Peripherally blocks impulse generation with BK sensitive chemoreceptors
Comments
Both exhibit antipyretic & analgesic properties
PD
Ibuprofen
CNS
- Analgesia
- Antipyretic
- Peripheral ↓ n. sensitisation to pain
CVS
- Oedema & exac HF
- Variable antiplatelet activity
Resp – bronchospasm
GI – GI ulceration, bleeding
GU
- ↓renal BF
- ↑urea
Papillary necrosis
Paracetamol
CNS
- Analgesia
- Antipyretic
Commets
Paracetamol has a more straightforward PD profile with less side effects when dosed correctly
PK
Ibuprofen
A
OBA 80%
D
>99% PPB
VD 0.15L/kg
M
Hepatic → oxidation to inactive metabolites +/- conjugated prior to excretion
E
Metabolites via urine
t ½ 2 hrs
Paracetamol
A
High lipid solubility
Rapid absorption
OBA 60 – 90%
More PR (OBA)
D
pKa 9.5 (weak acid)
<1% PPB
Highly UNIONISED at pH 7.4
Lipid soluble
Penetrates BBB +++
VD 1L/kg
M
HER 0.3
80% to glucuronide & sulphate
10% to NAPGI via CYP450 which is then conjugated with glutathione
E
<5% unchanged in urine
Metabolites actively secreted into renal tubules
t ½ B 2 – 4hrs
Comments
Both rely on liver and kidneys for metabolism & clearance
A/E
Ibuprofen
Fluid retention
Abdo pain
N&V
Vertigo
Dizziness
Dyspepsia
Nephrotoxic
Paracetamol
Irreversible Liver & Kidney toxicity w overdose
Comments
Both need to be used w caution in patients w renal/hepatic impairment
However, unlike paracetamol, the margin of safety w Ibuprofen is high and not associated with serious ADRs in case of overdose
D/I
Ibuprofen
Caution/ do not use with ACEI & ARBs
Risk of increased GI bleeding when used w other NSAIDs
Increased thrombotic risk when given w aspirin due to COX1 competition
Paracetamol
Drug may lead to increased INR in patients taking warfarin (reduced synthesis of Vit K dep clotting factors)
Comments
Brufen does not interact w warfarin but concurrent use of NSAIDs w anticoagulants increases the risk of bleeding, and this risk is further increased by concominant use of paracetamol
- Author: Krisoula Zahariou